Dec 13,2015

Regulations on Reporting and Monitoring of Adverse Drug Reactions

"Measures for the Reporting and Monitoring of Adverse Drug Reactions" (Ministry of Health Order No. 81) issued on May 4, 2011, Ministry of Health of the People's Republic of China Order No. 81. The "Measures for the Reporting and Monitoring of Adverse Drug Reactions" were reviewed and approved at the Ministry of Health executive meeting on December 13, 2010, and are hereby promulgated, effective from July 1, 2011. Minister Chen Zhu May 4, 2011 Adverse Drug Reaction Reporting and Monitoring

See more+

Dec 13,2015

Drug Recall Management Measures

Order No. 29 of the State Food and Drug Administration: The "Drug Recall Management Measures" was reviewed and approved by the State Food and Drug Administration's bureau meeting on December 6, 2007, and is hereby promulgated and shall come into effect from the date of promulgation. Director Shao Mingli December 10, 2007 Drug Recall Management Measures Chapter 1 General Provisions Article 1 To strengthen drug safety supervision and ensure public medication safety, in accordance with the "Drug Administration Law of the People's Republic of China," the "Implementation Regulations of the Drug Administration Law of the People's Republic of China," and the "State Council's Special Regulations on Strengthening the Supervision and Administration of Food and Other Product Safety"

See more+

Dec 13,2015

Good Manufacturing Practice for Pharmaceutical Products 2010 Revision

Good Manufacturing Practice for Pharmaceutical Products (2010 Revision) (Ministry of Health Order No. 79) Issued on February 12, 2011 Ministry of Health of the People's Republic of China Order No. 79 The "Good Manufacturing Practice for Pharmaceutical Products (2010 Revision)" was reviewed and approved by the Ministry of Health Executive Meeting on October 19, 2010, and is hereby promulgated, effective from March 1, 2011. Minister Chen Zhu January 17, 2011 Chapter 1 General Provisions Article 1 To standardize the quality management of pharmaceutical production, in accordance with the "Drug Administration Law of the People's Republic of China" and the "China

See more+

Dec 13,2015

Good Supply Practice for Pharmaceutical Products

Good Manufacturing Practice for Pharmaceutical Operation (Ministry of Health Order No. 90) National Health and Family Planning Commission of the People's Republic of China www.moh.gov.cn Order No. 90 The "Good Manufacturing Practice for Pharmaceutical Operation" was reviewed and approved by the Ministry of Health's executive meeting on November 6, 2012, and is hereby promulgated, effective from June 1, 2013. Minister Chen Zhu January 22, 2013 Good Manufacturing Practice for Pharmaceutical Operation Chapter 1 General Provisions Article 1 To strengthen the quality management of pharmaceutical operation, regulate pharmaceutical operation behavior, and ensure the safety and effectiveness of human medication, according to

See more+

Contact us

Add:

Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China

Board Office:

Domestic Sales:

International Sales:

Complaint & Report Hotline:

Pharmacovigilance Hotline:

Company Email:

Investor Relations:

International Sales Email:

Complaint/Report Email:

二维码

WeChat mini-site

二维码

WeChat official account


© Copyright 2025 Jiangxi Institute of Biological Products Inc. | SEO

Business License

Powered by www.300.cn